January 6, 2022
6:30 pm - 8:00 pm
Texas Pharmacy Association and Dallas Area Pharmacy Association
An Overview of the Opioid Epidemic and Pharmacy’s Role in Addressing Prescription Drug Abuse
DEA, Drug Diversion-Safety Implications
Thursday, January 6, 2022
6:30 p.m. – 7:30 p.m.
Due to local data, predicted increase in COVID-19 cases, and Omicron variant’s transmissibility, the DEA and DAPA has decided to move this meeting to an ALL VIRTUAL EVENT.
We at DAPA want to do our best to keep our healthcare workers safe and the spread of COVID-19 in our community.
1 Contact Hour (0.1 CEU)
At the completion of this activity, pharmacists and technicians will be able to:
1. Discuss the opioid abuse epidemic on a state and national level and the factors that have contributed to the current crisis
2. Define the prescribing and monitoring of the dispensing of controlled substances, including the use of PMP
3. Describe the pharmacists’ role in addressing and preventing prescription drug abuse
4. Explain regulatory compliance, legislative, and enforcement aspects of opioid abuse.
Registration Fees: $25*
ACPE credit will be uploaded to the CPE Monitor no more than six weeks after the program to all registrants who login, complete an evaluation form and satisfy all other stated criteria. Participants must provide their NABP CPE ID number to receive CE credit.
Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Credit has been approved with the Accreditation Council for Pharmacy Education for 0.1 CEU credits and 1 Contact Hours credit. This credit is valid until 1/6/2025.
Sponsored by Kroger Health
PLEASE fill out EVERY ASPECT of the form ACCURATELY and CLEARLY as possible. ACPE CE approval requires the information that we are requesting to approve your CE!
*$25 for Non-Members
*$10 for Members
*Free for Students!